prma digital applications

Improve the quality of your HTA submissions with our expert insight into dynamic payer thinking

Adapt your evidence generation strategy in line with the dynamically evolving HTA landscape
Understand payer expectations, appropriate comparators, value perception, and pricing potential with our critical insight
Develop effective HTA strategies quickly with cross-team engagement and synthesized information

We appreciate that one of the key challenges in developing an appropriate market access strategy is keeping up-to-date with the rapidly advancing treatment landscape and dynamic payer thinking. A deep understanding of pricing and reimbursement decisions, how payers have attempted to dilute value, and how these perspectives are evolving is critical to making the right investment decisions.

  • Updates at your fingertips on just published regulatory, reimbursement/HTA, and pricing decisions, augmented by in-depth analysis of the submitted evidence and payer feedback

  • Easily digestible price and HTA decision information on dashboards and interactive graphs, across comparator products and HTA agencies

  • Facilitates early optimization of trial design and key evidence generation activities

  • Enables your evidence base to be strengthened in line with the evolving HTA landscape

  • Promotes accelerated cross-team collaboration and alignment in the development of effective HTA strategies

  • Enhances your decision-making with our critical analysis, interpretation, and recommendations in regular discussion with your team

  • CASE STUDY

    Leading pharma launches new immunotherapy using insight from the PRMA Tracker®

    To support the successful launch of a new immunotherapy for a fast-evolving indication, this noted pharmaceutical company required an in-depth understanding of the latest payer thinking across rapidly advancing global markets. Find out how they approached the challenge.

    WHITEPAPER

    How are digital applications transforming the value and access functions?

    Pharmaceutical and biotechnology companies are turning to technology more frequently to solve business issues, and are increasingly using digital technology to optimize market access for their products. We believe that there are three key benefits for market access.

    The regular strategic updates on P&R and HTA decisions are an absolute asset.
    Market Access Manager, top-10 pharmaceutical company

    The team are impressed with the insight and recommendations specific to our key challenges.
    Country market access manager, top-20 pharmaceutical company

    Request a demonstration

    Our user friendly applications and expert team have supported organizations around the world in achieving their goals. We are always happy to have an informal, confidential chat and help you re-think your market access challenges.

    First name *

    * Please enter your first name

    Last name *

    * Please enter your last name

    Email *

    * Please enter an email address
     

    info@prmaconsulting.com
    UK (HQ) +44 (0)1252 786284
    US +1 (415) 655 6798

    Company registration number: 05893400

    Follow us


    Members of